Ethereum Leads With $155M Inflows Amid Market Volatilityby John Darbie 18.08.2024Ethereum sees $155M inflows, topping $862M YTD, while Bitcoin attracts $13M amid market uncertainty.
66% of Ethereum Addresses Now Profitableby John Darbie 18.08.2024IntoTheBlock data reveals 66% of ETH addresses in profit, with ETH near $2,600, up from prior lows.
Home Depot Adjusts 2024 Forecast Amid Economic Concernsby Mark Eisenberg 17.08.2024Home Depot revises 2024 outlook, forecasting decline in sales and earnings amid economic uncertainty and high interest rates.
WeRide Gains Permit for Robotaxi Trials in Californiaby Mark Eisenberg 15.08.2024WeRide can now test robotaxis with passengers in California, but can't charge fares. The move precedes a potential $5B IPO.
Glanbia Sees Strong H1 2024 Growth, EPS Up 12.4%by Mark Eisenberg 15.08.2024Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.
Could Bitcoin Become a U.S. Strategic Reserve?by John Darbie 15.08.2024Exploring Bitcoin's potential as a U.S. strategic reserve amid growing institutional interest and political challenges.
Ethereum’s Crucial EVM Overhaul with EOF Proposalby John Darbie 14.08.2024Ethereum set to overhaul EVM for enhanced security in smart contracts, balancing risks and benefits with EOF proposal.
IO Biotech Exceeds Q2 2024 EPS Expectationsby Lilu Anderson 14.08.2024IO Biotech's Q2 2024 EPS beats estimates, reporting -31 cents vs. expected -35 cents, despite no revenue.
Top Biotech Stocks to Watch: Expert Analysisby Lilu Anderson 13.08.2024Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
Dogecoin Analysis: Volume Up, Price Steadyby John Darbie 10.08.2024Dogecoin's price stalls despite rising trade volume, indicating cautious market sentiment. Analysts anticipate potential bullish trends.